Cargando…

Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers

PURPOSE: Recent studies indicated undisputed contribution of connective tissue growth factor (CTGF) in the development of many cancers, including non-small cell lung cancer (NSCLC). However, the functional role and regulation of CTGF expression during tumorigenesis remain elusive. Our goal was to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Drzewiecka, Hanna, Gałęcki, Bartłomiej, Jarmołowska-Jurczyszyn, Donata, Kluk, Andrzej, Dyszkiewicz, Wojciech, Jagodziński, Paweł P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978771/
https://www.ncbi.nlm.nih.gov/pubmed/27393180
http://dx.doi.org/10.1007/s00432-016-2195-3
_version_ 1782447216837787648
author Drzewiecka, Hanna
Gałęcki, Bartłomiej
Jarmołowska-Jurczyszyn, Donata
Kluk, Andrzej
Dyszkiewicz, Wojciech
Jagodziński, Paweł P.
author_facet Drzewiecka, Hanna
Gałęcki, Bartłomiej
Jarmołowska-Jurczyszyn, Donata
Kluk, Andrzej
Dyszkiewicz, Wojciech
Jagodziński, Paweł P.
author_sort Drzewiecka, Hanna
collection PubMed
description PURPOSE: Recent studies indicated undisputed contribution of connective tissue growth factor (CTGF) in the development of many cancers, including non-small cell lung cancer (NSCLC). However, the functional role and regulation of CTGF expression during tumorigenesis remain elusive. Our goal was to determine CTGF transcript and protein levels in tumoral and matched control tissues from 98 NSCLC patients, to correlate the results with clinicopathological features and to investigate whether the CTGF expression can be epigenetically regulated in NSCLC. METHODS: We used quantitative PCR, Western blotting and immunohistochemistry to evaluate CTGF expression in lung cancerous and histopathologically unchanged tissues. We tested the impact of 5-Aza-2′-deoxycytidine (5-dAzaC) and trichostatin A (TSA) on CTGF transcript and protein levels in NSCLC cells (A549, Calu-1). DNA methylation status of the CTGF regulatory region was evaluated by bisulfite sequencing. The influence of 5-dAzaC and TSA on NSCLC cells viability and proliferation was monitored by the trypan blue assay. RESULTS: We found significantly decreased levels of CTGF mRNA and protein (both p < 0.0000001) in cancerous tissues of NSCLC patients. Down-regulation of CTGF occurred regardless of gender in all histological subtypes of NSCLC. Moreover, we showed that 5-dAzaC and TSA were able to restore CTGF mRNA and protein contents in NSCLC cells. However, no methylation within CTGF regulatory region was detected. Both compounds significantly reduced NSCLC cells proliferation. CONCLUSIONS: Decreased expression of CTGF is a common feature in NSCLC; however, it can be restored by the chromatin-modifying agents such as 5-dAzaC or TSA and consequently restrain cancer development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00432-016-2195-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4978771
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49787712016-08-18 Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers Drzewiecka, Hanna Gałęcki, Bartłomiej Jarmołowska-Jurczyszyn, Donata Kluk, Andrzej Dyszkiewicz, Wojciech Jagodziński, Paweł P. J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: Recent studies indicated undisputed contribution of connective tissue growth factor (CTGF) in the development of many cancers, including non-small cell lung cancer (NSCLC). However, the functional role and regulation of CTGF expression during tumorigenesis remain elusive. Our goal was to determine CTGF transcript and protein levels in tumoral and matched control tissues from 98 NSCLC patients, to correlate the results with clinicopathological features and to investigate whether the CTGF expression can be epigenetically regulated in NSCLC. METHODS: We used quantitative PCR, Western blotting and immunohistochemistry to evaluate CTGF expression in lung cancerous and histopathologically unchanged tissues. We tested the impact of 5-Aza-2′-deoxycytidine (5-dAzaC) and trichostatin A (TSA) on CTGF transcript and protein levels in NSCLC cells (A549, Calu-1). DNA methylation status of the CTGF regulatory region was evaluated by bisulfite sequencing. The influence of 5-dAzaC and TSA on NSCLC cells viability and proliferation was monitored by the trypan blue assay. RESULTS: We found significantly decreased levels of CTGF mRNA and protein (both p < 0.0000001) in cancerous tissues of NSCLC patients. Down-regulation of CTGF occurred regardless of gender in all histological subtypes of NSCLC. Moreover, we showed that 5-dAzaC and TSA were able to restore CTGF mRNA and protein contents in NSCLC cells. However, no methylation within CTGF regulatory region was detected. Both compounds significantly reduced NSCLC cells proliferation. CONCLUSIONS: Decreased expression of CTGF is a common feature in NSCLC; however, it can be restored by the chromatin-modifying agents such as 5-dAzaC or TSA and consequently restrain cancer development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00432-016-2195-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-07-08 2016 /pmc/articles/PMC4978771/ /pubmed/27393180 http://dx.doi.org/10.1007/s00432-016-2195-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article – Cancer Research
Drzewiecka, Hanna
Gałęcki, Bartłomiej
Jarmołowska-Jurczyszyn, Donata
Kluk, Andrzej
Dyszkiewicz, Wojciech
Jagodziński, Paweł P.
Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title_full Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title_fullStr Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title_full_unstemmed Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title_short Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
title_sort decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
topic Original Article – Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978771/
https://www.ncbi.nlm.nih.gov/pubmed/27393180
http://dx.doi.org/10.1007/s00432-016-2195-3
work_keys_str_mv AT drzewieckahanna decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers
AT gałeckibartłomiej decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers
AT jarmołowskajurczyszyndonata decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers
AT klukandrzej decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers
AT dyszkiewiczwojciech decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers
AT jagodzinskipawełp decreasedexpressionofconnectivetissuegrowthfactorinnonsmallcelllungcancerisassociatedwithclinicopathologicalvariablesandcanberestoredbyepigeneticmodifiers